Susanna Melkas is senior neurologist at the Helsinki University Hospital and assistant professor in neurological rehabilitation at the University of Helsinki. She received her medical degree 2001 at the Karolinska Institute and PhD 2011 at the University of Helsinki. Her research focuses on cerebral small vessel disease, traumatic brain injuries and neurological rehabilitation.
Prof Anne Remes is acting as the Dean of Faculty of Medicine at the University of Oulu. She has a broad expertise in clinical as well as translational research in early onset dementias. The research focus is on genetics, biomarkers and early clinical manifestations of Alzheimer’s disease and frontotemporal dementia. She is the founder of Finnish FTD Research Network (FinFTD, @FinFtd). International collaboration is conducted strongly together with GENFI and FROTIERS networks. She is acting as the President of Union Council of The Alzheimer Society of Finland. List of publications includes 155 international original publications, Google scholar H-index is 37, Citations 10355.
Prof Anne Koivisto, specialist in neurology, is acting currently at the University of Eastern Finland and Kuopio University Hospital. She also consults at the Helsinki University Hospital and has professorship at the University of Helsinki. Her research as well as clinical work focuses widely on memory disorders, especially Alzheimer’s disease and idiopathic normal pressure hydrocephalus. International collaboration is conducted together with EADC, NIDD and AI-Mind networks but she also has collaborators eg in USA, Australia and Japan. List of publications includes over 100 international peer reviewed original publications. She is acting as Chair of the National Committee that evaluates Special Competences in Memory Disorders, Deputy Chair of the Union Council of the Alzheimer Society of Finland and member of the Ministry of Social Affairs and Health National Scientific Council of Aging.
Perttu Lindsberg M.D. is Professor of Neurology, Chairman of the Department of Clinical Neurosciences, University of Helsinki. He works also as Chief Physician in the Department of Neurology, Helsinki University Hospital. His research has focused on basic mechanisms of acute ischemic injury and cerebrovascular disease, both in experimental models and in clinical settings. Lindsberg undertook 3-year research fellowship in Bethesda, Maryland, USA, before starting residency in Neurology in Helsinki University Hospital during 1990s. He acted as the Chief Physician of Neurology in the Emergency Room during the pivotal period when thrombolytic therapy of ischemic stroke was initiated. By collecting unique clinical sample banks, he established long-standing research projects unraveling the inflammatory mechanisms of human ischemic brain injury and atherosclerotic carotid artery disease. More recently, his scientific efforts have been focused on identifying circulating biomarkers of acute stroke and intracerebral hemorrhage.
Dr. Hanna Jokinen is a specialized neuropsychologist and a senior researcher at the Helsinki University Hospital and the University of Helsinki, Finland. She has published scientific papers on vascular cognitive impairment since 2004, runs neuropsychological research within multidisciplinary study projects and participates in several international research collaborations. Dr. Jokinen has focused her work on comprehensive neuropsychological assessment of cognitive symptoms related to cerebrovascular disease, detailed evaluation of domain-specific cognitive impairments (executive dysfunction in particular), early MRI predictors of progressive cognitive decline as well as determinants of functional disability in cerebral small vessel disease.
Liisa Myllykangas MD, PhD, is a consultant neuropathologist, group leader and clinical instructor at the University of Helsinki and Helsinki University Hospital. She qualified from University of Helsinki and has also previously worked at Mayo Clinic Jacksonville and Harvard Medical School. Dr. Myllykangas’s wide research portfolio comprises of neuropathological, genetic and experimental studies on various neurological diseases in humans and Drosophila. Her group’s work on the population-based Vantaa85+ cohort has made significant contributions to our understanding of the brain pathology of the oldest old population, including characterization of two common forms of alpha-synuclein pathology in Dementia with Lewy Bodies. In addition, her group has identified gene defects of > 10 familial forms of neurodegenerative and cerebrovascular disorders, including novel alpha-synuclein and COL4A1 mutations.
Dr. Lauri Soinne serves as a senior researcher, lecturer and Adjunct Professor in Clinical Neurology at the University of Helsinki. His main research interests have been acute stroke treatment and cerebral hemodynamics, but also cognitive functioning, white matter disease, and atherosclerosis. He has served as an investigator/principal investigator in many stroke trials, and worked in the field of neuropharmacology.